Meloxicam Supplier-Buyer Network — Trade Flow Analysis

Name: Meloxicam Supplier-Buyer Trade Network Dataset — 277+ Indian Exporters, 14+ Importers, 100+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Meloxicam supplier network, Meloxicam buyers, pharmaceutical export India, Meloxicam trade data

TransData Nexus

Meloxicam

India Pharmaceutical Trade Intelligence

$199.4M277 Suppliers100 CountriesHS 30049066

ExportsIndia → UNITED STATES86.3%India → SERBIA3.0%

ImportsUNITED STATES → India$1.1M GERMANY → India$19.9K

#1 Supplier: UNICHEM LABORATORIES #1 Buyer: UNICHEM PHARMACEUTICALS

Who Supplies Meloxicam? Top Manufacturers & Buyers 2026 — UNICHEM LABORATORIES LIMITED Leads | TransData Nexus | TransData Nexus

1UNICHEM LABORATORIES LIMITED

UNICHEM LABORATORIES LIMITED is the first-largest Meloxicam exporter from India, with a market share of 69.1% and a total export value of $137.8M across 368 shipments. Their average shipment value of $374.5K is above the market average of $60.5K, suggesting premium or bulk contract pricing.

UNICHEM LABORATORIES LIMITED serves 5 named buyers in our database. UNICHEM PHARMACEUTICALS (USA) INC is the dominant customer, accounting for 62.7% of this supplier's tracked business. Top customers include:

• UNICHEM PHARMACEUTICALS (USA) INC — $86.4M across 231 shipments (62.7% of this supplier's total exports)

• UNICHEM PHARMACEUTICALS (USA) INC — $43.9M across 117 shipments (31.8% of this supplier's total exports)

• PHARMAS D.O.O. — $6.0M across 16 shipments (4.3% of this supplier's total exports)

• UNICHEM PHARMACEUTICALS (USA) INC — $962.0K across 3 shipments (0.7% of this supplier's total exports)

• NICHE GENERICS LTD. — $610.8K across 2 shipments (0.4% of this supplier's total exports)

Key Insight: UNICHEM LABORATORIES LIMITED's per-shipment value of $374.5K is 519% above the market average of $60.5K, consistent with large-order contracts or value-added formulations.

2CIPLA LIMITED

CIPLA LIMITED is the second-largest Meloxicam exporter from India, with a market share of 12.3% and a total export value of $24.6M across 889 shipments. Their average shipment value of $27.6K is below the market average of $60.5K, reflecting a high-volume, competitive pricing strategy.

CIPLA LIMITED serves 5 named buyers in our database. CIPLA USA INC UPS SUPPLY CHAIN SOL is the dominant customer, accounting for 93.3% of this supplier's tracked business. Top customers include:

• CIPLA USA INC UPS SUPPLY CHAIN SOL — $22.9M across 830 shipments (93.3% of this supplier's total exports)

• CIPLA USA INC UPS SUPPLY CHAIN SOL — $1.2M across 44 shipments (5.0% of this supplier's total exports)

• SANDOZ PTY LIMITED — $165.1K across 6 shipments (0.7% of this supplier's total exports)

• SANDOZ PTY LTD. SAND — $138.8K across 5 shipments (0.6% of this supplier's total exports)

• SANDOZ PTY LTD — $105.6K across 4 shipments (0.4% of this supplier's total exports)

Key Insight: CIPLA LIMITED operates with high shipment frequency (889 shipments) at a per-shipment value of $27.6K, indicating a broad distribution network with many smaller, regular orders.

3ZYDUS LIFESCIENCES LIMITED

ZYDUS LIFESCIENCES LIMITED is the third-largest Meloxicam exporter from India, with a market share of 2.6% and a total export value of $5.1M across 184 shipments. Their average shipment value of $27.9K is below the market average of $60.5K, reflecting a high-volume, competitive pricing strategy.

ZYDUS LIFESCIENCES LIMITED serves 5 named buyers in our database. EVERSANA LIFE SCIENCE SERVICES is the dominant customer, accounting for 91.4% of this supplier's tracked business. Top customers include:

• EVERSANA LIFE SCIENCE SERVICES — $4.7M across 168 shipments (91.4% of this supplier's total exports)

• PRIORITY HEALTHCARE — $210.5K across 8 shipments (4.1% of this supplier's total exports)

• ZYDUS HEALTHCARE SA — $106.4K across 4 shipments (2.1% of this supplier's total exports)

• PHARMALAND (1982) CO — $71.2K across 3 shipments (1.4% of this supplier's total exports)

• PRIORITY HEALTHCARE — $54.1K across 2 shipments (1.1% of this supplier's total exports)

Key Insight: ZYDUS LIFESCIENCES LIMITED operates with high shipment frequency (184 shipments) at a per-shipment value of $27.9K, indicating a broad distribution network with many smaller, regular orders.

4LUPIN LIMITED

LUPIN LIMITED is the fourth-largest Meloxicam exporter from India, with a market share of 1.8% and a total export value of $3.7M across 30 shipments. Their average shipment value of $122.6K is above the market average of $60.5K, suggesting premium or bulk contract pricing.

LUPIN LIMITED serves 1 named buyer in our database. UPS SUPPLY CHAIN SOL is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• UPS SUPPLY CHAIN SOL — $3.7M across 30 shipments (100.0% of this supplier's total exports)

Key Insight: LUPIN LIMITED's per-shipment value of $122.6K is 103% above the market average of $60.5K, consistent with large-order contracts or value-added formulations.

5VANTAGE INTERNATIONAL (INDIA) INC

VANTAGE INTERNATIONAL (INDIA) INC is the fifth-largest Meloxicam exporter from India, with a market share of 1.2% and a total export value of $2.5M across 6 shipments. Their average shipment value of $411.9K is above the market average of $60.5K, suggesting premium or bulk contract pricing.

VANTAGE INTERNATIONAL (INDIA) INC serves 1 named buyer in our database. NA is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• NA — $2.5M across 6 shipments (100.0% of this supplier's total exports)

Key Insight: VANTAGE INTERNATIONAL (INDIA) INC's per-shipment value of $411.9K is 581% above the market average of $60.5K, consistent with large-order contracts or value-added formulations.

6MACLEODS PHARMACEUTICALS LTD

MACLEODS PHARMACEUTICALS LTD is the fifth-largest Meloxicam exporter from India, with a market share of 0.6% and a total export value of $1.1M across 17 shipments. Their average shipment value of $65.2K is above the market average of $60.5K, suggesting premium or bulk contract pricing.

MACLEODS PHARMACEUTICALS LTD serves 2 named buyers in our database. CAMEL INTERNATIONAL is the dominant customer, accounting for 96.1% of this supplier's tracked business. Top customers include:

• CAMEL INTERNATIONAL — $1.1M across 16 shipments (96.1% of this supplier's total exports)

• PLANETPHARMA — $42.8K across 1 shipments (3.9% of this supplier's total exports)

Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $65.2K is 8% above the market average of $60.5K, consistent with large-order contracts or value-added formulations.

1United States

United States ranks as the first-largest destination for Meloxicam imports from India, with a total trade value of $172.0M across 971 shipments — representing a 86.3% share of all Meloxicam exports. The average shipment value of $177.2K is above the global average of $60.5K, indicating high-value procurement contracts or branded formulations. This market is served by 7 tracked buyers.

Named Meloxicam importers in United States: UNICHEM PHARMACEUTICALS (USA) INC.. is the largest buyer, accounting for 50.3% ($86.6M) of this market's total imports.

• UNICHEM PHARMACEUTICALS (USA) INC.. — $86.6M (50.3% of United States's total)

• UNICHEM PHARMACEUTICALS (USA) INC. — $44.7M (26.0% of United States's total)

• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $25.3M (14.7% of United States's total)

Key Insight: United States's per-shipment average of $177.2K (193% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Meloxicam imports from India.

Primary Market

Secondary Market

2Serbia

Serbia ranks as the second-largest destination for Meloxicam imports from India, with a total trade value of $6.0M across 0 shipments — representing a 3.0% share of all Meloxicam exports. The average shipment value of $6.0M is above the global average of $60.5K, indicating high-value procurement contracts or branded formulations.

Key Insight: Serbia's per-shipment average of $6.0M (9781% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Serbia is a key market for Meloxicam imports from India.

Primary Market

Secondary Market

3Australia

Australia ranks as the third-largest destination for Meloxicam imports from India, with a total trade value of $3.1M across 88 shipments — representing a 1.6% share of all Meloxicam exports. The average shipment value of $35.2K is below the global average of $60.5K, consistent with generic/API volume purchasing. This market is served by 3 tracked buyers.

Named Meloxicam importers in Australia: GENERIC PARTNERS PTY LTD is the largest buyer, accounting for 27.2% ($843.8K) of this market's total imports.

• GENERIC PARTNERS PTY LTD — $843.8K (27.2% of Australia's total)

• SANDOZ PTY LTD, — $479.5K (15.5% of Australia's total)

• APOTEX PTY LTD., — $288.3K (9.3% of Australia's total)

Key Insight: Australia receives frequent, smaller shipments of Meloxicam — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Australia is a key market for Meloxicam imports from India.

Primary Market

Secondary Market

4Nigeria

Nigeria ranks as the fourth-largest destination for Meloxicam imports from India, with a total trade value of $2.9M across 0 shipments — representing a 1.5% share of all Meloxicam exports. The average shipment value of $2.9M is above the global average of $60.5K, indicating high-value procurement contracts or branded formulations.

Key Insight: Nigeria's per-shipment average of $2.9M (4765% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Nigeria is a key market for Meloxicam imports from India.

Primary Market

Secondary Market

5Vietnam

Vietnam ranks as the fifth-largest destination for Meloxicam imports from India, with a total trade value of $2.5M across 8 shipments — representing a 1.3% share of all Meloxicam exports. The average shipment value of $317.4K is above the global average of $60.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Meloxicam importers in Vietnam: ALLEGENS COMPANY LIMITED is the largest buyer, accounting for 22.2% ($563.7K) of this market's total imports.

• ALLEGENS COMPANY LIMITED — $563.7K (22.2% of Vietnam's total)

Key Insight: Vietnam's per-shipment average of $317.4K (425% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Vietnam is a key market for Meloxicam imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Meloxicam.
2.Flow Mapping: 277 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,297 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 100 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

3,297 Verified Shipments

277 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Meloxicam

Meloxicam

Who Supplies Meloxicam? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Meloxicam? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Meloxicam Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1UNICHEM LABORATORIES LIMITED

2CIPLA LIMITED

3ZYDUS LIFESCIENCES LIMITED

4LUPIN LIMITED

5VANTAGE INTERNATIONAL (INDIA) INC

6MACLEODS PHARMACEUTICALS LTD

From Indian Factories to Global Pharmacies — How Meloxicam Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Meloxicam Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Serbia

3Australia

4Nigeria

5Vietnam

People Also Ask — Meloxicam Supplier & Trade Network

Meloxicam Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology